ES2100558T3 - Antiepilepticos analogos del vpa. - Google Patents
Antiepilepticos analogos del vpa.Info
- Publication number
- ES2100558T3 ES2100558T3 ES93918997T ES93918997T ES2100558T3 ES 2100558 T3 ES2100558 T3 ES 2100558T3 ES 93918997 T ES93918997 T ES 93918997T ES 93918997 T ES93918997 T ES 93918997T ES 2100558 T3 ES2100558 T3 ES 2100558T3
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- image
- formulae
- hydrogen
- antiepilepticos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000003556 anti-epileptic effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 230000003390 teratogenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/18—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon triple bonds as unsaturation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
- C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
- C07C53/134—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings monocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Peptides Or Proteins (AREA)
- Socks And Pantyhose (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Electrotherapy Devices (AREA)
Abstract
LA INVENCION SE REFIERE A COMPUESTOS, QUE SON ANTIEPILEPTICOS ACTIVOS DISPONIENDO SOLAMENTE DE ACCION SEDANTE BAJA O TERATOGENICA Y DISPONIENDO DE FORMULAS (I), (II), (III) O (IV) PUDIENDO TENER LOS COMPUESTOS DE LAS FORMULAS (I) Y (II) MULTIPLES ENLACES NO SATURADOS, DONDE R1, R2, R3 Y R4, INDEPENDIENTE UNO DE OTRO, PUEDEN SER UN GRUPO C1 - C6 - ALQUIL, R5 ES HIDROGENO O UN GRUPO C1 - C2 - ALQUIL Y DONDE EN LOS COMPUESTOS DE LAS FORMULAS (I) Y (II) AL MENOS UNO DE LOS RESTOS R1 HASTA R4 ES DIFERENTE DE HIDROGENO. EN LOS COMPUESTOS DE LA FORMULA (I) PARA EL CASO DE QUE UN ATOMO DE CARBONO ESTE PRESENTE EN LA POSICION 2 SE FORMA UN CENTRO DE ASIMETRIA, Y LOS COMPUESTOS DE LAS FORMULAS (II), (III) Y (IV) SE ENCUENTRAN PRESENTES EN FORMA DE SUS RACEMATOS, SUS ENANTIOMEROS PUROS O UNA DE LAS MEZCLAS DIFERENTES DE RACEMATO DE SUS ENANTIOMEROS, Y SUS SALES TOLERABLES FARMACEUTICAMENTE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4231085A DE4231085A1 (de) | 1992-09-12 | 1992-09-12 | VPA-analoge Antiepileptika |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2100558T3 true ES2100558T3 (es) | 1997-06-16 |
Family
ID=6468160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93918997T Expired - Lifetime ES2100558T3 (es) | 1992-09-12 | 1993-09-10 | Antiepilepticos analogos del vpa. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5786380A (es) |
| EP (1) | EP0659172B1 (es) |
| JP (1) | JP2887419B2 (es) |
| KR (1) | KR100244883B1 (es) |
| AT (1) | ATE151067T1 (es) |
| AU (1) | AU683425B2 (es) |
| CA (1) | CA2144419A1 (es) |
| DE (2) | DE4231085A1 (es) |
| DK (1) | DK0659172T3 (es) |
| ES (1) | ES2100558T3 (es) |
| GR (1) | GR3023558T3 (es) |
| NZ (2) | NZ255317A (es) |
| WO (1) | WO1994006743A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW248552B (es) | 1993-06-01 | 1995-06-01 | Onoda Yakuhin Kogyo Kk | |
| US6300373B1 (en) * | 1993-09-10 | 2001-10-09 | American Biogenetic Sciences, Inc. | Antiproliferative and neurotrophic molecules |
| US5672746A (en) * | 1994-08-30 | 1997-09-30 | American Biogenetic Sciences, Inc. | Antiproliferative and neurotrophic molecules |
| US5717109A (en) * | 1994-09-08 | 1998-02-10 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| IL124118A (en) * | 1998-04-16 | 2007-09-20 | Yissum Res Dev Co | Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, method for their synthesis and pharmaceutical compositions containing them |
| IL140415A0 (en) | 1998-06-22 | 2002-02-10 | American Biogenetic Sciences | The use of valproic acid analog for the treatment and prevention of migraine and affective illness |
| CA2335603A1 (en) * | 1998-06-22 | 1999-12-29 | Heinz Nau | Alpha-fluoro alkynoic acids with anticonvulsant activity |
| US6969732B2 (en) * | 1999-04-12 | 2005-11-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them |
| DE10002945A1 (de) * | 2000-01-13 | 2001-07-26 | Heinz Nau | Verfahren zur Herstellung von enantiomerenreinen Analoga der Valproinsäure |
| US6521790B2 (en) | 2000-11-01 | 2003-02-18 | Abbott Laboratories | Alkynyl amides and their therapeutic applications |
| DE10393475B4 (de) * | 2002-10-09 | 2014-09-25 | Waters Technologies Corp. (N.D.Ges.D. Staates Delaware) | Verfahren und Vorrichtung zur Identifizierung von Verbindungen in einer Probe |
| US20060223888A1 (en) * | 2002-12-16 | 2006-10-05 | Abbott Frank S | Valproic acid analogues and pharmaceutical composition thereof |
| US20110313037A1 (en) * | 2008-12-20 | 2011-12-22 | Saakian Susanna A | [2.2.2] Bicyclic Derivatives and Methods of Use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2442M (fr) * | 1962-10-17 | 1964-04-06 | Henry Eugene | L'acide dipropylacétique et ses dérivés en tant que nouveuax médicaments dépresseurs du systeme nerveux central. |
| DE2854195A1 (de) * | 1978-12-15 | 1980-06-26 | Technochemie Gmbh | Verfahren zur herstellung von dipropylessigsaeure |
| DE3718803A1 (de) * | 1987-06-02 | 1988-12-15 | Desitin Arzneimittel Gmbh | Verfahren zur herstellung von e-2-propyl-2-pentensaeure und physiologisch vertraeglichen salzen derselben |
-
1992
- 1992-09-12 DE DE4231085A patent/DE4231085A1/de not_active Withdrawn
-
1993
- 1993-09-10 NZ NZ255317A patent/NZ255317A/en unknown
- 1993-09-10 JP JP6507680A patent/JP2887419B2/ja not_active Expired - Fee Related
- 1993-09-10 WO PCT/DE1993/000861 patent/WO1994006743A1/de not_active Ceased
- 1993-09-10 AT AT93918997T patent/ATE151067T1/de not_active IP Right Cessation
- 1993-09-10 NZ NZ299727A patent/NZ299727A/xx unknown
- 1993-09-10 DE DE59306054T patent/DE59306054D1/de not_active Expired - Fee Related
- 1993-09-10 DK DK93918997.3T patent/DK0659172T3/da active
- 1993-09-10 CA CA002144419A patent/CA2144419A1/en not_active Abandoned
- 1993-09-10 EP EP93918997A patent/EP0659172B1/de not_active Expired - Lifetime
- 1993-09-10 AU AU49442/93A patent/AU683425B2/en not_active Ceased
- 1993-09-10 KR KR1019950700951A patent/KR100244883B1/ko not_active Expired - Fee Related
- 1993-09-10 ES ES93918997T patent/ES2100558T3/es not_active Expired - Lifetime
-
1994
- 1994-11-23 US US08/344,810 patent/US5786380A/en not_active Expired - Fee Related
-
1997
- 1997-05-26 GR GR970401209T patent/GR3023558T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0659172A1 (de) | 1995-06-28 |
| DK0659172T3 (da) | 1997-05-05 |
| AU4944293A (en) | 1994-04-12 |
| NZ255317A (en) | 1996-12-20 |
| GR3023558T3 (en) | 1997-08-29 |
| KR100244883B1 (ko) | 2000-02-15 |
| DE59306054D1 (de) | 1997-05-07 |
| JPH08502045A (ja) | 1996-03-05 |
| ATE151067T1 (de) | 1997-04-15 |
| WO1994006743A1 (de) | 1994-03-31 |
| NZ299727A (en) | 2000-11-24 |
| US5786380A (en) | 1998-07-28 |
| CA2144419A1 (en) | 1994-03-31 |
| DE4231085A1 (de) | 1994-03-17 |
| EP0659172B1 (de) | 1997-04-02 |
| HK1008016A1 (en) | 1999-04-30 |
| AU683425B2 (en) | 1997-11-13 |
| JP2887419B2 (ja) | 1999-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2100558T3 (es) | Antiepilepticos analogos del vpa. | |
| FI840603A0 (fi) | (2-oxo-1,2,3,5-tetrahydroimidazo/2,1-b/kinazolinyl)-oxialkylamider | |
| SE9001329L (sv) | Adamantanderivat foer att foerhindra och behandla cerebral ischemi | |
| GEP20002210B (en) | Acridine Derivatives | |
| ES2194986T3 (es) | Compuestos de carbonil-piperazinilo y piperidinilo que inhiben la farnesil-protein-transferasa. | |
| ES8306141A1 (es) | Un procedimiento para la produccion de un derivado de carbostirilo | |
| DK0642516T3 (da) | Makrocykliske immunmodulatorer | |
| ATE132144T1 (de) | Chalkonderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
| DE69115526D1 (de) | 2,4-Pyrimidindionderivate und diese enthaltende Arzneimittel | |
| ES2098023T3 (es) | Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen. | |
| ATE166648T1 (de) | Benzoxazinderivate, deren herstellung und deren verwendung in therapie | |
| ES8500887A1 (es) | Un procedimiento para la preparacion de nuevos derivados de propanolamina. | |
| ES2108862T3 (es) | Diamidas imidocarbonimidicas n,n' substituidas derivadas de hidroxilaminas. | |
| PH30129A (en) | Sertindole prodrug compositions and use | |
| ATE113030T1 (de) | Hydroxyalkancarbonsäure-derivate und deren verwendung. | |
| TW328957B (en) | Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation | |
| DE69103630D1 (de) | Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen. | |
| ES8400109A1 (es) | "un procedimiento para preparar esteres de acido 3-metilflavon-8-carboxilico". | |
| ES8200648A2 (es) | Procedimiento de preparacion de compuestos opacificantes para radiografia y similares | |
| IL84983A0 (en) | Guanidinoacetic and ethanamidinoacetic acid derivatives as sweetening agents and sweetening compositions containing the same | |
| ES435361A1 (es) | Un metodo para la preparacion de nuevos esteres alcohilicosde aminoacidos. | |
| ATE156798T1 (de) | Penten-derivate, deren herstellung und verwendung | |
| DE69203401D1 (de) | 2-Aminopyrimidin-4-Carboxamidderivate, deren Herstellung und deren Verwendung als Heilmittel. | |
| TW226021B (es) | ||
| ATE108779T1 (de) | 2,3-dihydroxychinoxalinverbindungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 659172 Country of ref document: ES |